Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Colombia
Management Report
Published: January 2010
Pages: 56
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The Colombian pharmaceutical market is the fifth largest in Latin America. The majority of the market is supplied by the relatively well-developed domestic industry. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments fo
According to the Economist Intelligence Unit (EIU), the popularity of the President, Álvaro Uribe, remains high. He is expected to be able to continue in power, if he is allowed to run in the presidential elections running in May 2010. The country has felt some effects from the current global credit crisis, but GDP is expected to grow by 2.4% in real terms in 2010. Demographically, the country has the third largest population in Latin America, which is an attractive market, but those aged 65 and over only represent 5.8% of the total. Legally, an argument between the White House and Congress stopped a TPA agreement between the USA and Colombia being fast-tracked, which might have enforced IP regulations, perhaps delaying it indefinitely.
The Colombian pharmaceutical market is the fifth largest in the region. The economic recovery is expected to slightly encourage expenditure on health and insurance, therefore the market will increase by a moderate CAGR at retail prices between 2010 and 2015. In the retail pharmacy sector, POM and OTC medicines maintain a similar market share compared to previous years. Pharmaceutical imports and exports are expected to rise due to an increasing demand for pharmaceuticals. Market fragmentation continues due to the high number of pharmaceutical companies operating in the market. Increasing gross pharmaceutical production is expected to create more jobs.
The majority of the market is supplied by the relatively well-developed domestic industry. Despite having this, the country consistently runs a negative balance of trade in pharmaceuticals. Imports of both raw materials and finished medicaments have increased in recent years, with a particularly high import growth for raw materials. The major pharmaceutical producers are subsidiaries of international companies, but only a few are left. The largest indigenous manufacturers are Bussié, Genfar, Lafrancol, La Santé, Procaps and Tecnoquímicas which produce generic copycats. Tecnoquimicas announced the purchase of the largest pharmaceutical laboratory in El Salvador, Teramed, in October 2009, for the sum of US$30 million, as part of a Central American expansion plan.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
According to the Economist Intelligence Unit (EIU), the popularity of the President, Álvaro Uribe, remains high. He is expected to be able to continue in power, if he is allowed to run in the presidential elections running in May 2010. The country has felt some effects from the current global credit crisis, but GDP is expected to grow by 2.4% in real terms in 2010. Demographically, the country has the third largest population in Latin America, which is an attractive market, but those aged 65 and over only represent 5.8% of the total. Legally, an argument between the White House and Congress stopped a TPA agreement between the USA and Colombia being fast-tracked, which might have enforced IP regulations, perhaps delaying it indefinitely.
The Colombian pharmaceutical market is the fifth largest in the region. The economic recovery is expected to slightly encourage expenditure on health and insurance, therefore the market will increase by a moderate CAGR at retail prices between 2010 and 2015. In the retail pharmacy sector, POM and OTC medicines maintain a similar market share compared to previous years. Pharmaceutical imports and exports are expected to rise due to an increasing demand for pharmaceuticals. Market fragmentation continues due to the high number of pharmaceutical companies operating in the market. Increasing gross pharmaceutical production is expected to create more jobs.
The majority of the market is supplied by the relatively well-developed domestic industry. Despite having this, the country consistently runs a negative balance of trade in pharmaceuticals. Imports of both raw materials and finished medicaments have increased in recent years, with a particularly high import growth for raw materials. The major pharmaceutical producers are subsidiaries of international companies, but only a few are left. The largest indigenous manufacturers are Bussié, Genfar, Lafrancol, La Santé, Procaps and Tecnoquímicas which produce generic copycats. Tecnoquimicas announced the purchase of the largest pharmaceutical laboratory in El Salvador, Teramed, in October 2009, for the sum of US$30 million, as part of a Central American expansion plan.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel